Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Nykode Therapeutics ASA Director's Dealing 2021

Apr 22, 2021

3695_dirs_2021-04-22_308b4b05-6d06-4fef-a9ff-440046941252.html

Director's Dealing

Open in viewer

Opens in your device viewer

Mandatory notification of trade - party related to primary insider

Mandatory notification of trade - party related to primary insider

Primary insider Christian Åbyholm, a member of the VACCIBODY AS board, represents Andenaesgruppen (including Kvantia AS and Christiania Skibs AS). As part of a process to streamline the ownership structure of Andenaesgruppen, Kvantia AS has today sold 700,000 Vaccibody shares to Finyield AS at NOK 74 per share. Finyield AS is one of the owners of Kvantia AS. After the transaction Christian Åbyholm (board member) through Caaby AS holds 1,995,895 Vaccibody shares and 100,000 warrants and Andenaesgruppen (through Kvantia AS and Christiania Skibs AS) represented by Christian Åbyholm owns 17,170,575 Vaccibody shares and in addition Norda ASA represented by Christian Åbyholm owns 7,996,755 Vaccibody shares.